Global Subcutaneous Drug Delivery Devices Market
Pharmaceuticals

Comprehensive Analysis of the Subcutaneous Drug Delivery Devices Market 2025-2034: Growth Rates, Trends, and Future Opportunities

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the subcutaneous drug delivery devices market grown in recent years?

The subcutaneous drug delivery devices market has expanded significantly, expected to grow from $27.66 billion in 2024 to $29.77 billion in 2025, with a CAGR of 7.6%. Growth in the past was driven by the rising prevalence of chronic diseases, increased demand for self-administered medications, higher diabetes and obesity rates, patient preference for convenience, and an aging population.

How is the subcutaneous drug delivery devices market size expected to evolve during the forecast period?

The subcutaneous drug delivery devices market is set for strong growth, reaching $39.57 billion by 2029 at a CAGR of 7.4%. Growth drivers include expansion in the biologics and biosimilars market, rising use of wearable drug delivery systems, increasing focus on personalized medicine, improving healthcare reimbursement policies, and growing demand for home healthcare solutions. Key trends include the integration of digital health technologies, the rise of smart and connected devices, increased adoption of minimally invasive procedures, advancements in needle-free injection systems, and the emergence of AI-driven device development.

Get your subcutaneous drug delivery devices market report here!

https://www.thebusinessresearchcompany.com/report/subcutaneous-drug-delivery-devices-global-market-report

Which key drivers are propelling the subcutaneous drug delivery devices market’s growth?

The increasing prevalence of diabetes and cardiovascular diseases (CVD) is expected to propel the growth of the subcutaneous drug delivery devices market. The rise in these diseases is attributed to aging populations, unhealthy lifestyles, and limited access to preventive healthcare. Subcutaneous drug delivery devices are essential in managing these chronic conditions, providing a controlled method for delivering insulin, anticoagulants, and other medications. In April 2023, the British Diabetic Association reported that 4.3 million people in the UK are living with diabetes, and in May 2024, the CDC noted that heart disease claimed 702,880 lives in 2022. Consequently, the rising incidence of these diseases is driving growth in the subcutaneous drug delivery devices market.

What are the market segments in the subcutaneous drug delivery devices industry?

The subcutaneous drug delivery devicesmarket covered in this report is segmented –

1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps

2) By Application: Diabetes, Fertility, Oncology

3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers

Subsegments:

1) Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens

2) Pen Needles: Standard Pen Needles, Safety Pen Needles

3) Injector Pens: Disposable Injector Pens, Reusable Injector Pens

4) Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors

5) Implantable Pumps: Insulin Pumps, Drug Infusion Pumps

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp

Which leading companies are shaping the growth of the subcutaneous drug delivery devices market?

Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

What key trends are currently impacting the subcutaneous drug delivery devices market’s development?

Prominent businesses in the subcutaneous drug delivery devices market are putting their resources into the creation of novel products, such as tiny digital fluid flow sensors, in order to improve the safety and accuracy of subcutaneous drug delivery by providing precise, customizable flow detectors for large-volume injection devices. These mini digital fluid flow sensors are compact tools designed to accurately gauge the flow velocity of liquids in small-scale uses, offering a digital feedback for precise supervision and regulation. As an example, in May 2024, Sensirion AG, a firm headquartered in Switzerland and specializing in environmental and flow sensors, introduced the SLD3x sensor platform. This series of sensors boasts highly precise digital fluid flow sensors whose features can be personalized, ensuring accurate flow measurement, detection of blockages, identification of in-line air bubbles, and liquid temperature monitoring. For large-scale medical device production, these tiny sensors are ideal, guaranteeing precise dosing and improved patient safety in subcutaneous drug delivery.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19723

Which geographic areas are influencing the growth of the subcutaneous drug delivery devices market?

North America was the largest region in the subcutaneous drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Pharmaceutical Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Inhalation And Nasal Spray Generic Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/inhalation-and-nasal-spray-generic-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *